|
|
|
|
| TRADING CENTER |
5.05+0.09 / +1.81%
QLT Inc. (NASDAQ GS:QLTI)
5.050.00 / 0.00
After hours quote
Prev. Close:
4.96
Open:
4.97
High:
5.12
Low:
4.96
Volume:
512,800
Volume Avg.:
501,700
52wk Range:
1.40 - 5.00
Market Cap (mil):
275.89
P/E Ratio:
16.83
Dividend Yield:
N/A
| QLT Inc. establishes sales force in the United States - PR Newswire | |
| Prospecting for Stocks: QLT - MotleyFool.com | |
| QLT initiates Phase Ib study of QLT091001 in Leber Congenital Amaurosis - PR Newswire | |
| 6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with po... - PR Newswire | |
| QLT announces MGH litigation settlement - PR Newswire |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 57.35 | 0.13 / 0.23% | 10.97 |
| GILD | Gilead Sciences Inc | 43.01 | -0.23 / -0.53% | 16.61 |
| CELG | Celgene Corporation | 56.80 | 0.51 / 0.91% | 68.43 |
Short Interest Date:
Nov 30 2009
Short Interest Shares:
1,124,420
Short Interest Ratio:
2.3
Float:
54,241,400
Short Interest as a % of Float:
3.6%
Average Daily Volume:
399,400
Outstanding Shares:
54,630,692
QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies. The company's research and development efforts are focused on the discovery and development of pharmaceutical products in the ophthalmology field. It currently has ... (more)
| 2008 Revenue: | $124.1 M | Headquarters: Vancouver, B.C., |
| Employees: | 254 | CEO: Robert L. Butchofsky |
| Net Income: | $134.9 M | Industry: Biotechnology |
| Market Cap: | $271.0 M | Website: www.qltinc.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| QLTI | 5.05 | +0.09 / +1.81% | 4.96 | 5.12 | 4.96 | Profile Chart News |
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved.
Terms under which this service is provided to you. Privacy Policy. Advertising Practices.
Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
| Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data. Fundamental data provided by Morningstar, Inc.. SEC Filings data provided by Edgar Online Inc.. Earnings data provided by FactSet CallStreet, LLC. |
